查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493386

上游生物製程市场规模、份额、趋势分析报告：按产品、按工作流程、按使用类型、按模式、按地区、细分市场预测，2024-2030 年

Upstream Bioprocessing Market Size, Share & Trends Analysis Report By Product, By Workflow, By Use Type, By Mode, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

上游生物製程市场的成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球上游生物製程市场规模将达到592.4亿美元，2024年至2030年复合年增长率为14.3%。

生物製药的商业性成功和广泛接受为多家专有和契约製造生物製药公司提供了利润丰厚的成长途径。此外，对生物相似药和生技药品的高需求、推出具有成本效益的改进技术以及对一次性系统的接受度提高等因素正在共同推动市场的收益表现。

新兴企业和新参与企业在建造新的生物製造工厂时经常面临预算限制。因此，这些营业单位正在透过将製造流程委託给合约服务来扩大其生物治疗产品组合，有助于增加上游生物製程服务的收益。

连续的上游生物製程为生物加工产业带来了显着的效益。对于反应器培养物的澄清，越来越多地引入声波技术和连续离心等方法，这往往会最大限度地减少澄清的负担。这导致更高的细胞培养密度和更有效率的上游工程。

由于细胞株在蛋白质表现和克隆筛检方面生产力的持续进步，预计细胞培养产品在预测期内将具有最快的复合年增长率。细胞培养被认为是上游生物加工中最困难和关键的步骤，因此在技术复杂性方面需要更多的关注，从而占据了上游生物加工市场的最大份额。

多用途系统等因素在于，这些系统需要一次性投资，利用率高，可应用于更大量的生物过程，并能准确维持pH和氧气。然而，从传统不銹钢反应器到一次性反应器系统的模式转移一直是一次性产业利润丰厚成长的因素。

主要市场开拓参与者正在采取新产品开发、互利合作伙伴关係、协议和地理扩张等策略性倡议，以加强其在市场中的地位。例如，2019年2月，丹纳赫公司达成协议，收购通用电气生命科学公司的生物製药业务。透过此次收购，丹纳赫将 GE BioPharma 的细胞培养基、一次性技术、开发设备和消耗品添加到其现有产品组合中，扩大了其市场份额。

上游生物製程市场报告亮点

  • 反应器的高可用性以及主要参与者不断推出一次性反应器正在为反应器领域带来显着的收益占有率。
  • 拥有内部生物製造能力的成熟生物製药製造公司的存在为该领域带来了最大的收益占有率。
  • 由于投资增加以及透过 CMO 将一次性系统整合到工厂以扩大製造能力，外包产业预计在预测期内将以最高的复合年增长率成长。
  • 北美市场占据主导地位，2023 年占 36.2% 的份额。这是生物技术持续创新以及该地区对生物製药日益偏好的结果。此外，美国众多生物製药製造商的存在和大量投资也支持了成长。
  • 亚太地区是市场成长最快的地区，预计在预测期内复合年增长率为 17.4%。这是由于人们越来越认识到可用于上游工作流程中进程内控制的快速分析方法。

目录

第一章上游生物製程市场：调查方法与范围

第二章上游生物製程市场：执行摘要

  • 市场展望
  • 分部展望
  • 竞争考察

第三章上游生物製程市场：变数、趋势、范围

  • 市场体系展望
  • 市场动态
  • 上游生物製程市场分析工具

第四章上游生物製程市场：产品估算与趋势分析

  • 细分仪表板
  • 全球上游生物製程市场产品波动分析
  • 2018-2030年全球上游生物製程市场规模及趋势分析（依产品）
  • 反应器/发酵罐
  • 细胞培养产品
  • 筛选
  • 反应器器配件
  • 袋子和容器
  • 其他的

第五章上游生物製程市场：工作流程估计与趋势分析

  • 细分仪表板
  • 全球上游生物製程市场工作流程变化分析
  • 2018-2030 年全球上游生物製程市场规模与趋势分析（依工作流程）
  • 培养基製备
  • 细胞培养
  • 细胞分离

第六章上游生物製程市场：使用类型估计与趋势分析

  • 细分仪表板
  • 全球上游生物製程市场使用类型变化分析
  • 2018-2030 年全球上游生物製程市场规模及趋势分析（依使用类型）
  • 多次使用
  • 一次使用

第七章上游生物製程市场：模式估计与趋势分析

  • 细分仪表板
  • 全球上游生物製程市场模式波动分析
  • 2018-2030年全球上游生物製程市场规模及趋势分析（分模式）
  • 公司内部
  • 外包

第八章上游生物製程市场：区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析：
  • 北美洲
    • 2018-2030年北美市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 2018年至2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 挪威
    • 瑞典
  • 亚太地区
    • 2018-2030 年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 2018-2030 年拉丁美洲市场估计与预测
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 2018年至2030年中东和非洲市场估计和预测
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Thermo Fisher Scientific, Inc.
    • Merck KGaA
    • Corning Incorporated
    • Sartorius AG
    • Eppendorf AG
    • Danaher
    • Boehringer Ingelheim GmbH
    • Applikon Biotechnology
    • PBS Biotech, Inc.
    • Lonza
    • VWR International, LLC
    • Meissner Filtration Products, Inc.
    • Repligen Corporation
    • Entegris
    • Kuhner AG
Product Code: GVR-3-68038-592-2

Upstream Bioprocessing Market Growth & Trends:

The global upstream bioprocessing market size is expected to reach USD 59.24 billion by 2030, registering a CAGR of 14.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher's market presence with the addition of GE Biopharma's cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Upstream Bioprocessing Market Report Highlights:

  • High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
  • Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
  • The outsourced segment is expected to grow at the highest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
  • North America dominated the market and accounted for a share of 36.2% in 2023 as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
  • Asia Pacific is expected to be the fastest-growing region in the market and is expected to grow at a CAGR of 17.4% during the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Table of Contents

Chapter 1. Upstream Bioprocessing Market: Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Workflow
    • 1.1.3. Use Type
    • 1.1.4. Mode
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Upstream Bioprocessing Market: Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Workflow outlook
    • 2.2.3. Use type outlook
    • 2.2.4. Mode outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Upstream Bioprocessing Market: Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Upstream Bioprocessing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Upstream Bioprocessing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Upstream Bioprocessing Market Product Movement Analysis
  • 4.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Bioreactors/Fermenters
    • 4.4.1. Bioreactors/fermenters market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Cell Culture Products
    • 4.5.1. Cell Culture Products market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Filters
    • 4.6.1. Filters market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Bioreactors Accessories
    • 4.7.1. Bioreactors accessories market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.8. Bags & Containers
    • 4.8.1. Bags & containers market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Upstream Bioprocessing Market: Workflow Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Upstream Bioprocessing Market Workflow Movement Analysis
  • 5.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Workflow, 2018 to 2030 (USD Million)
  • 5.4. Media Preparation
    • 5.4.1. Media preparation market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Cell Culture
    • 5.5.1. Cell culture market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Cell Separation
    • 5.6.1. Cell separation market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Upstream Bioprocessing Market: Use Type Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Upstream Bioprocessing Market Use Type Movement Analysis
  • 6.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Use Type, 2018 to 2030 (USD Million)
  • 6.4. Multi-use
    • 6.4.1. Multi-use market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Single-use
    • 6.5.1. Single-use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Upstream Bioprocessing Market: Mode Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global Upstream Bioprocessing Market Mode Movement Analysis
  • 7.3. Global Upstream Bioprocessing Market Size & Trend Analysis, by Mode, 2018 to 2030 (USD Million)
  • 7.4. In-house
    • 7.4.1. In-house market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Outsourced
    • 7.5.1. Outsourced market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Upstream Bioprocessing Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Market Share Analysis, 2023 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Regulatory framework
    • 8.4.3. Canada
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Canada market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. Regulatory framework
  • 8.5. Europe
    • 8.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. UK market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. Regulatory framework
    • 8.5.3. Germany
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Germany market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. Regulatory framework
    • 8.5.4. France
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. France market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Regulatory framework
    • 8.5.5. Italy
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Italy market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. Regulatory framework
    • 8.5.6. Spain
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Spain market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Regulatory framework
    • 8.5.7. Denmark
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.7.3. Competitive scenario
      • 8.5.7.4. Regulatory framework
    • 8.5.8. Norway
      • 8.5.8.1. Key country dynamics
      • 8.5.8.2. Norway market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.8.3. Competitive scenario
      • 8.5.8.4. Regulatory framework
    • 8.5.9. Sweden
      • 8.5.9.1. Key country dynamics
      • 8.5.9.2. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.5.9.3. Competitive scenario
      • 8.5.9.4. Regulatory framework
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Japan market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Regulatory framework
    • 8.6.3. China
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. China market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.3.3. Competitive scenario
      • 8.6.3.4. Regulatory framework
    • 8.6.4. India
      • 8.6.4.1. Key country dynamics
      • 8.6.4.2. India market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.4.3. Competitive scenario
      • 8.6.4.4. Regulatory framework
    • 8.6.5. Australia
      • 8.6.5.1. Key country dynamics
      • 8.6.5.2. Australia market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.5.3. Competitive scenario
      • 8.6.5.4. Regulatory framework
    • 8.6.6. South Korea
      • 8.6.6.1. Key country dynamics
      • 8.6.6.2. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.6.3. Competitive scenario
      • 8.6.6.4. Regulatory framework
    • 8.6.7. Thailand
      • 8.6.7.1. Key country dynamics
      • 8.6.7.2. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.6.7.3. Competitive scenario
      • 8.6.7.4. Regulatory framework
  • 8.7. Latin America
    • 8.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Regulatory framework
    • 8.7.3. Mexico
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. Regulatory framework
    • 8.7.4. Argentina
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Regulatory framework
  • 8.8. MEA
    • 8.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key country dynamics
      • 8.8.2.2. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.8.2.3. Competitive scenario
      • 8.8.2.4. Regulatory framework
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key country dynamics
      • 8.8.3.2. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.8.3.3. Competitive scenario
      • 8.8.3.4. Regulatory framework
    • 8.8.4. UAE
      • 8.8.4.1. Key country dynamics
      • 8.8.4.2. UAE market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.8.4.3. Competitive scenario
      • 8.8.4.4. Regulatory framework
    • 8.8.5. Kuwait
      • 8.8.5.1. Key country dynamics
      • 8.8.5.2. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
      • 8.8.5.3. Competitive scenario
      • 8.8.5.4. Regulatory framework

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2023
  • 9.4. Company Profiles/Listing
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company overview
      • 9.4.1.2. Financial performance
      • 9.4.1.3. Product benchmarking
      • 9.4.1.4. Strategic initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Company overview
      • 9.4.2.2. Financial performance
      • 9.4.2.3. Product benchmarking
      • 9.4.2.4. Strategic initiatives
    • 9.4.3. Corning Incorporated
      • 9.4.3.1. Company overview
      • 9.4.3.2. Financial performance
      • 9.4.3.3. Product benchmarking
      • 9.4.3.4. Strategic initiatives
    • 9.4.4. Sartorius AG
      • 9.4.4.1. Company overview
      • 9.4.4.2. Financial performance
      • 9.4.4.3. Product benchmarking
      • 9.4.4.4. Strategic initiatives
    • 9.4.5. Eppendorf AG
      • 9.4.5.1. Company overview
      • 9.4.5.2. Financial performance
      • 9.4.5.3. Product benchmarking
      • 9.4.5.4. Strategic initiatives
    • 9.4.6. Danaher
      • 9.4.6.1. Company overview
      • 9.4.6.2. Financial performance
      • 9.4.6.3. Product benchmarking
      • 9.4.6.4. Strategic initiatives
    • 9.4.7. Boehringer Ingelheim GmbH
      • 9.4.7.1. Company overview
      • 9.4.7.2. Financial performance
      • 9.4.7.3. Product benchmarking
      • 9.4.7.4. Strategic initiatives
    • 9.4.8. Applikon Biotechnology
      • 9.4.8.1. Company overview
      • 9.4.8.2. Financial performance
      • 9.4.8.3. Product benchmarking
      • 9.4.8.4. Strategic initiatives
    • 9.4.9. PBS Biotech, Inc.
      • 9.4.9.1. Company overview
      • 9.4.9.2. Financial performance
      • 9.4.9.3. Product benchmarking
      • 9.4.9.4. Strategic initiatives
    • 9.4.10. Lonza
      • 9.4.10.1. Company overview
      • 9.4.10.2. Financial performance
      • 9.4.10.3. Product benchmarking
      • 9.4.10.4. Strategic initiatives
    • 9.4.11. VWR International, LLC
      • 9.4.11.1. Company overview
      • 9.4.11.2. Financial performance
      • 9.4.11.3. Product benchmarking
      • 9.4.11.4. Strategic initiatives
    • 9.4.12. Meissner Filtration Products, Inc.
      • 9.4.12.1. Company overview
      • 9.4.12.2. Financial performance
      • 9.4.12.3. Product benchmarking
      • 9.4.12.4. Strategic initiatives
    • 9.4.13. Repligen Corporation
      • 9.4.13.1. Company overview
      • 9.4.13.2. Financial performance
      • 9.4.13.3. Product benchmarking
      • 9.4.13.4. Strategic initiatives
    • 9.4.14. Entegris
      • 9.4.14.1. Company overview
      • 9.4.14.2. Financial performance
      • 9.4.14.3. Product benchmarking
      • 9.4.14.4. Strategic initiatives
    • 9.4.15. Kuhner AG
      • 9.4.15.1. Company overview
      • 9.4.15.2. Financial performance
      • 9.4.15.3. Product benchmarking
      • 9.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global upstream bioprocessing market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 5 Global upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 6 Global upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 7 North America upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 8 North America upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 9 North America upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 10 North America upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 11 North America upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 12 U.S. upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 13 U.S. upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 14 U.S. upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 15 U.S. upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 16 Canada upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Canada upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 18 Canada upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 19 Canada upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 20 Europe upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 21 Europe upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 23 Europe upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 24 Europe upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 25 Germany upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 27 Germany upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 28 Germany upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 29 UK upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 31 UK upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 32 UK upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 33 France upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 34 France upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 35 France upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 36 France upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 37 Italy upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 39 Italy upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 40 Italy upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 41 Spain upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 43 Spain upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 44 Spain upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 45 Denmark upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 47 Denmark upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 48 Denmark upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 49 Norway upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 50 Norway upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 51 Norway upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 52 Norway upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 53 Sweden upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 54 Sweden upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 55 Sweden upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 56 Sweden upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 62 China upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 63 China upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 64 China upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 65 China upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 66 Japan upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Japan upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 68 Japan upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 69 Japan upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 70 India upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 71 India upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 72 India upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 73 India upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 74 South Korea upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 75 South Korea upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 76 South Korea upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 77 South Korea upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 78 Australia upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 79 Australia upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 80 Australia upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 81 Australia upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 82 Thailand upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 83 Thailand upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 84 Thailand upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 85 Thailand upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 86 Latin America upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 87 Latin America upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 88 Latin America upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 89 Latin America upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 90 Latin America upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 91 Brazil upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 92 Brazil upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 93 Brazil upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 94 Brazil upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 95 Mexico upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 96 Mexico upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 97 Mexico upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 98 Mexico upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 99 Argentina upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 100 Argentina upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 101 Argentina upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 102 Argentina upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 103 MEA upstream bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 104 MEA upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 105 MEA upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 106 MEA upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 107 MEA upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 108 South Africa upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 109 South Africa upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 110 South Africa upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 111 South Africa upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 112 Saudi Arabia upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 116 UAE upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 117 UAE upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 118 UAE upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 119 UAE upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)
  • Table 120 Kuwait upstream bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 121 Kuwait upstream bioprocessing market, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Kuwait upstream bioprocessing market, by use type, 2018 - 2030 (USD Million)
  • Table 123 Kuwait upstream bioprocessing market, by mode, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Upstream bioprocessing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market snapshot
  • Fig. 13 Segment snapshot 1
  • Fig. 14 Segment snapshot 2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Biotechnology market value, 2023 (USD billion)
  • Fig. 17 Market trends & outlook
  • Fig. 18 PESTEL analysis
  • Fig. 19 Porter's Five Forces analysis
  • Fig. 20 Upstream bioprocessing market: Product outlook & key takeaways
  • Fig. 21 Upstream bioprocessing market: Product movement analysis
  • Fig. 22 Global bioreactors/fermenters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Global cell culture products market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Global filters market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Global bioreactors accessories market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Global bags & containers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Global others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Upstream bioprocessing market: Workflow outlook & key takeaways
  • Fig. 29 Upstream bioprocessing market: Workflow movement analysis
  • Fig. 30 Global media preparation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Global cell culture market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Global cell separation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Upstream bioprocessing market: Use type outlook & key takeaways
  • Fig. 34 Upstream bioprocessing market: Use type movement analysis
  • Fig. 35 Global multi-use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Global single-use market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Upstream bioprocessing market: Mode outlook & key takeaways
  • Fig. 38 Upstream bioprocessing market: Mode movement analysis
  • Fig. 39 Global in-house market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Global outsourced market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Regional marketplace outlook, 2023 & 2030 (USD Billion)
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Key country dynamics
  • Fig. 45 U.S. upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Key country dynamics
  • Fig. 47 Canada upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Europe upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Germany upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Addressable aspects of upstream process: Sartorius AG
  • Fig. 52 Key country dynamics
  • Fig. 53 UK upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 France upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 Italy upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Spain upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Denmark upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Norway upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Sweden upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Asia Pacific upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Japan upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 China upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 India upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 Australia upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 Thailand upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 South Korea upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Latin America upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Brazil upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Mexico upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Argentina upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 86 MEA upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 South Africa upstream bioprocessing materials market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Saudi Arabia upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 UAE upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Kuwait upstream bioprocessing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Market participant categorization
  • Fig. 96 Global upstream bioprocessing market position analysis, 2023
  • Fig. 97 Strategic framework